By Counterforce Health Team in Blenrep (belantamab mafodotin) —

Work With Your Doctor to Get Blenrep (belantamab mafodotin) Covered by Humana in New Jersey: Provider Collaboration Guide

Quick Answer: Getting Blenrep Coverage Through Doctor Partnership

Current Status: Blenrep (belantamab mafodotin) was withdrawn from the U.S. market in 2022 and is under FDA review with a PDUFA date of October 23, 2025. Access is currently limited to clinical trials or expanded access programs.

Fastest Path: Work with your oncologist to request coverage through Humana's formulary exception process for compassionate use or trial participation. Your doctor must document medical necessity and lack of suitable alternatives. Start by having your oncologist contact Humana's prior authorization department at 877-486-2621 to discuss coverage options for investigational access.

First Step Today: Schedule an appointment with your oncologist to discuss your treatment history and gather documentation for a comprehensive medical necessity request.

Table of Contents

  1. Set Your Goal: Understanding What Approval Requires
  2. Visit Preparation: Building Your Clinical Story
  3. Evidence Kit: Gathering Supporting Documentation
  4. Medical Necessity Letter Structure
  5. Peer-to-Peer Review Support
  6. After-Visit Follow-Up
  7. Respectful Persistence and Escalation
  8. Appeals Process in New Jersey
  9. FAQ

Set Your Goal: Understanding What Approval Requires

Since Blenrep is currently withdrawn from the U.S. market, getting coverage requires a different approach than standard drug approvals. Your partnership with your oncologist is crucial because they must demonstrate:

Coverage Requirements for Withdrawn/Investigational Drugs

Medical Necessity Criteria:

  • Confirmed multiple myeloma diagnosis with documented progression
  • Failure or intolerance to available FDA-approved therapies
  • No suitable alternatives on Humana's formulary
  • Clinical rationale for why Blenrep specifically is needed

Access Pathways:

  • Clinical trial participation (standard care costs covered)
  • Expanded access/compassionate use program
  • Off-label procurement (rarely approved for withdrawn drugs)
Important: Humana Medicare Advantage plans have a 3.5% prior authorization denial rate but take investigational drug requests seriously when properly documented.

Your Role as Partner

Your job isn't to become a medical expert—it's to be an organized, informed advocate who helps your doctor build the strongest possible case. This means:

  • Providing complete treatment history
  • Documenting functional impact of disease progression
  • Understanding insurance terminology and deadlines
  • Supporting your doctor through the appeals process

Visit Preparation: Building Your Clinical Story

Before meeting with your oncologist, prepare a comprehensive overview of your multiple myeloma journey. This preparation makes the difference between a routine visit and one that produces compelling documentation for Humana.

Symptom Timeline Documentation

Create a detailed timeline including:

Disease Progression Markers:

  • When you first noticed symptoms returning or worsening
  • Specific functional limitations (fatigue, pain, mobility issues)
  • Recent hospitalizations or emergency visits
  • Changes in lab values you're aware of

Treatment Response History:

  • Each prior therapy with start/stop dates
  • Reason for discontinuation (progression, toxicity, intolerance)
  • Best response achieved with each treatment
  • Side effects that impacted quality of life

Functional Impact Assessment

Document how your condition affects daily activities:

  • Work or activity limitations
  • Need for assistance with daily tasks
  • Pain or fatigue levels
  • Sleep disruption
  • Social/family impact

This functional information helps your doctor articulate urgency in their medical necessity letter.

Evidence Kit: Gathering Supporting Documentation

Work with your healthcare team to compile a comprehensive evidence package. This documentation forms the foundation of your coverage request.

Essential Clinical Records

Recent Test Results (within 3 months):

  • Complete blood count and comprehensive metabolic panel
  • Serum protein electrophoresis and immunofixation
  • Serum free light chains
  • Beta-2 microglobulin and LDH
  • Recent imaging (CT, PET, MRI)

Pathology Documentation:

  • Original multiple myeloma diagnosis with bone marrow biopsy
  • Cytogenetics and FISH results
  • Any recent biopsies showing progression

Treatment History Summary:

  • Detailed list of all prior therapies
  • Response duration for each treatment
  • Toxicity reports and dose modifications
  • Reasons for treatment changes

Published Guidelines and Evidence

Your oncologist will reference these in their medical necessity letter:

Key Guidelines:

Comparative Effectiveness:

  • Documentation of why available alternatives (CAR-T, bispecifics, standard triplets) are inappropriate for your specific case

Medical Necessity Letter Structure

The medical necessity letter is the cornerstone of your coverage request. Here's what your oncologist should include based on Humana's documentation requirements:

Required Elements

Patient Demographics and Diagnosis:

  • Full name, DOB, Humana member ID
  • ICD-10 diagnosis code (C90.00 - Multiple myeloma not having achieved remission)
  • Date of original diagnosis and staging information

Clinical Rationale Section:

  • Current disease status with objective evidence of progression
  • Performance status (ECOG score)
  • Relevant comorbidities affecting treatment options

Treatment History Documentation:

  • Chronological list of all prior therapies
  • Response to each treatment with supporting data
  • Specific reasons why each treatment was discontinued
  • Why currently available options are inadequate

Blenrep-Specific Justification:

  • Mechanism of action and why it's uniquely suited for this patient
  • Reference to clinical trial data supporting efficacy
  • Plan for monitoring (including REMS requirements if applicable)

Risk-Benefit Analysis:

  • Risks of treatment delay
  • Expected benefits based on clinical profile
  • Monitoring and safety plan
Counterforce Health Tip: When insurers deny coverage for complex cases like withdrawn drugs seeking compassionate use, having a systematically documented medical necessity case significantly improves appeal success rates. Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals by analyzing denial letters and crafting point-by-point rebuttals aligned with each plan's specific criteria.

Supporting References

Your oncologist should cite:

  • FDA approval history and withdrawal rationale
  • Peer-reviewed studies demonstrating efficacy in your disease setting
  • Professional society guidelines supporting the approach
  • Lack of suitable formulary alternatives

Peer-to-Peer Review Support

If Humana initially denies your request, they may offer a peer-to-peer (P2P) review where your oncologist speaks directly with a Humana medical director. Your role is to support your doctor's preparation.

Pre-P2P Preparation

Availability Coordination:

  • Provide your oncologist with flexible time windows
  • Ensure they have uninterrupted time for the call
  • Offer to reschedule patient appointments if needed

Case Summary Preparation: Help your doctor prepare a concise case summary covering:

  • 30-second patient overview (age, diagnosis, stage, performance status)
  • Key prior treatments and failures
  • Why Blenrep is uniquely appropriate
  • Urgency factors and risks of delay

Documentation Ready:

  • All supporting records organized and accessible
  • Key guideline citations bookmarked
  • Specific denial reasons from Humana's letter addressed

During P2P Support

While you won't be on the call, you can:

  • Be available by phone for any factual questions
  • Have additional documentation ready to fax if requested
  • Take notes on any follow-up requirements

After-Visit Follow-Up

Maintaining momentum after your appointment is crucial for successful coverage requests.

Documentation Management

Save Everything:

  • Copies of all submitted forms and letters
  • Confirmation numbers from fax or portal submissions
  • Screenshots of online submission confirmations
  • Email correspondence with your healthcare team

Portal Communication:

  • Use your patient portal for follow-up questions
  • Request copies of letters sent on your behalf
  • Ask for updates on submission status

Timeline Tracking

Create a simple tracking system:

  • Submission date and method
  • Expected decision timeline (typically 72 hours for standard requests)
  • Follow-up dates if no response received
  • Appeal deadlines if denied
Tip: Humana has committed to deciding 95% of complete electronic PA requests within one business day by January 2026, but complex cases like investigational drugs may take longer.

Respectful Persistence and Escalation

Advocacy requires persistence balanced with professionalism. Here's how to escalate appropriately while maintaining good relationships with your healthcare team.

Communication Cadence

Week 1-2: Allow normal processing time

  • No contact needed unless urgent medical situation
  • Trust your healthcare team to follow standard timelines

Week 3: Gentle inquiry

  • Contact your oncologist's office to check status
  • Ask if any additional information has been requested

Week 4+: Active follow-up

  • Request peer-to-peer review if not already scheduled
  • Begin preparing for potential appeal

Escalation Scripts

For Insurance Follow-Up: "Hi, I'm calling to check on the status of my prior authorization request submitted on [date]. My member ID is [number]. Can you tell me if any additional information is needed?"

For Provider Office: "I wanted to check on my coverage request for Blenrep. I understand these cases are complex—is there anything I can do to help move the process forward?"

When to Escalate Further

Consider escalating if:

  • No response after 2 weeks beyond standard timeline
  • Request for additional information seems unreasonable
  • Denial appears to misunderstand your clinical situation

Appeals Process in New Jersey

New Jersey residents have strong appeal rights through the state's Independent Health Care Appeals Program (IHCAP), administered by Maximus Federal Services.

Humana Internal Appeals

Level 1: Redetermination

  • File within 65 days of denial notice
  • Decision within 7 calendar days (standard) or 72 hours (expedited)
  • Can be filed by you, your doctor, or authorized representative

Required Documentation:

  • Copy of denial letter
  • Additional medical evidence
  • Updated medical necessity letter addressing denial reasons

New Jersey External Review (IHCAP)

If Humana upholds the denial, New Jersey's external review process offers a second chance:

Eligibility:

  • Fully-insured plan issued in New Jersey (most Humana MA plans qualify)
  • Completed internal appeals process
  • Denial based on medical necessity or investigational status

Filing Process:

Key Advantage: Independent medical reviewers, not insurance company employees, make the final decision.

Important: The external review is free to you—Humana pays all costs. If the reviewers overturn the denial, Humana must provide coverage within 10 business days.

FAQ

How long does Humana prior authorization take in New Jersey? Standard requests: 72 hours for complete submissions. Complex investigational drug requests may take longer, but Humana is moving toward 1-business-day decisions for electronic submissions by 2026.

What if Blenrep is non-formulary on my Humana plan? You can request a formulary exception by having your doctor document that all covered alternatives would be less effective or cause adverse effects. Use Humana's Request for Medicare Prescription Drug Coverage Determination form.

Can I request an expedited appeal for Blenrep? Yes, if your doctor believes waiting could seriously harm your health. Expedited appeals must be decided within 72 hours for Medicare Advantage plans.

Does step therapy apply if I've failed treatments outside New Jersey? Treatment history from other states counts toward step therapy requirements. Ensure your doctor documents all prior therapies regardless of where they were received.

What counts as medical necessity for Blenrep? For a withdrawn drug, medical necessity typically requires documented failure of available alternatives, lack of suitable options, and compelling clinical rationale for why this specific agent is needed.

Can my doctor file appeals on my behalf? Yes, your prescribing physician can file appeals as your authorized representative. This is often more effective because they can provide immediate clinical clarification if questions arise.

What if I'm in a clinical trial for Blenrep? Humana should cover standard-of-care costs associated with trial participation. The investigational drug itself is provided by the study sponsor.

How do I contact New Jersey's insurance appeals program? Call the IHCAP hotline at 1-888-393-1062 or visit njihcap.maximus.com for external review information.

Sources & Further Reading

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider about your specific medical situation. Treatment decisions should be made in consultation with qualified medical professionals familiar with your individual case.

For additional support with complex insurance appeals, Counterforce Health helps patients and clinicians turn insurance denials into successful approvals through targeted, evidence-backed appeal strategies.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.